Lista de obras - Benjamin Pariente - Dominio Público Uruguay

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

scientific article published on 22 December 2019

Activation of the receptor NKG2D leads to production of Th17 cytokines in CD4+ T cells of patients with Crohn's disease.

artículo científico publicado en 2011

Adalimumab dose escalation is effective and well tolerated in Crohn's disease patients with secondary loss of response to adalimumab

artículo científico publicado en 2016

Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease

artículo científico publicado en 2014

Bowel damage and disability in Crohn's disease: a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability Index

scientific article published on 27 March 2020

Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study

artículo científico publicado en 2016

Cephalic duodenopancreatectomy for hyperalgic duodenal Crohn's disease fistulized in the pancreatic gland

artículo científico publicado en 2014

Changes in the Lémann Index Values During the First Years of Crohn's Disease

artículo científico publicado en 2015

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease

artículo científico publicado en 2017

Computed tomography evaluation of high-grade esophageal necrosis after corrosive ingestion to avoid unnecessary esophagectomy.

artículo científico publicado en 2014

Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.

artículo científico publicado en 2016

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.

artículo científico publicado en 2017

Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.

artículo científico publicado en 2014

Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.

artículo científico

Editorial: paradoxical skin lesions during anti-TNF treatment-an additional argument to consider new biologics as first line therapy in inflammatory bowel disease

artículo científico publicado en 2018

Editorial: the most commonly used IBD indices still fail to represent real life and subjective patient experience. Author's reply

artículo científico publicado en 2020

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

artículo científico publicado en 2016

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study

scientific article published on 14 April 2020

Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn’s Disease: A Prospective Cohort-Study in High-Risk Patients

artículo científico publicado en 2016

Endoscopic and clinical recurrences after laparoscopic or open ileocolic resection in Crohn's disease

artículo científico publicado en 2014

Endoscopy as a prognostic marker in inflammatory bowel disease.

artículo científico publicado en 2013

Esophagojejunostomy after total gastrectomy for caustic injuries.

artículo científico publicado en 2013

Extra-intestinal Manifestations at Diagnosis in Paediatric- and Elderly-onset Ulcerative Colitis are Associated With a More Severe Disease Outcome: A Population-based Study

artículo científico publicado en 2017

Fine-scale geographical distribution and ecological risk factors for Crohn's disease in France (2007-2014)

scientific article published on 06 October 2019

Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer.

artículo científico publicado en 2015

High carriage of adherent invasive E. coli in wildlife and healthy individuals.

artículo científico publicado en 2018

Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts Score.

artículo científico publicado en 2016

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort

artículo científico publicado en 2017

Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011].

artículo científico publicado en 2017

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, or Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.

artículo científico publicado en 2018

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

artículo científico publicado en 2018

Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn Disease

artículo científico publicado en 2016

Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study

Mo1909 Adalimumab Dose Escalation Is Effective and Well Tolerated in Crohn's Disease Patients With Secondary Loss of Response to Adalimumab

New tools and approaches for improved management of inflammatory bowel diseases.

artículo científico publicado en 2014

Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis

Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-α agents

artículo científico

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

artículo científico publicado en 2017

Post-operative complications in elderly onset inflammatory bowel disease: a population-based study

artículo científico publicado en 2018

Post-operative recurrence of Crohn's disease after definitive stoma: an underestimated risk

artículo científico publicado en 2016

Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.

artículo científico publicado en 2016

Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease

scientific article published on 29 May 2019

Reply

artículo científico publicado en 2016

Reply

artículo científico publicado en 2016

Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases.

artículo científico publicado en 2014

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)

scientific article published on 02 August 2018

Sa1960 Crohn's Disease Patients With High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

article

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study

artículo científico publicado en 2020

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

artículo científico

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

artículo científico publicado en 2015

T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence

scientific article published on 12 February 2019

Tailored treatment according to early post-surgery colonoscopy reduces clinical recurrence in Crohn's disease: a retrospective study

artículo científico publicado en 2014

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

artículo científico publicado en 2019

Treatments for Crohn’s Disease–Associated Bowel Damage: A Systematic Review

artículo científico publicado en 2018

Trough Levels and Antibodies to Infliximab May Not Predict Response to Intensification of Infliximab Therapy in Patients With Inflammatory Bowel Disease

scientific article published on 29 August 2011

Lista de obras de Benjamin Pariente

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

Activation of the receptor NKG2D leads to production of Th17 cytokines in CD4+ T cells of patients with Crohn's disease.

Adalimumab dose escalation is effective and well tolerated in Crohn's disease patients with secondary loss of response to adalimumab

Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease

Bowel damage and disability in Crohn's disease: a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability Index

Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study

Cephalic duodenopancreatectomy for hyperalgic duodenal Crohn's disease fistulized in the pancreatic gland

Changes in the Lémann Index Values During the First Years of Crohn's Disease

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease

Computed tomography evaluation of high-grade esophageal necrosis after corrosive ingestion to avoid unnecessary esophagectomy.

Costs of Crohn's Disease According to Severity States in France: A Prospective Observational Study and Statistical Modeling over 10 Years.

Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.

Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.

Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.

Editorial: paradoxical skin lesions during anti-TNF treatment-an additional argument to consider new biologics as first line therapy in inflammatory bowel disease

Editorial: the most commonly used IBD indices still fail to represent real life and subjective patient experience. Author's reply

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real-world cohort study

Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn’s Disease: A Prospective Cohort-Study in High-Risk Patients

Endoscopic and clinical recurrences after laparoscopic or open ileocolic resection in Crohn's disease

Endoscopy as a prognostic marker in inflammatory bowel disease.

Esophagojejunostomy after total gastrectomy for caustic injuries.

Extra-intestinal Manifestations at Diagnosis in Paediatric- and Elderly-onset Ulcerative Colitis are Associated With a More Severe Disease Outcome: A Population-based Study

Fine-scale geographical distribution and ecological risk factors for Crohn's disease in France (2007-2014)

Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer.

High carriage of adherent invasive E. coli in wildlife and healthy individuals.

Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts Score.

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort

Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011].

Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, or Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.

Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

Lymphoid Aggregates Remodel Lymphatic Collecting Vessels that Serve Mesenteric Lymph Nodes in Crohn Disease

Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study

Mo1909 Adalimumab Dose Escalation Is Effective and Well Tolerated in Crohn's Disease Patients With Secondary Loss of Response to Adalimumab

New tools and approaches for improved management of inflammatory bowel diseases.

Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis

Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-α agents

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Post-operative complications in elderly onset inflammatory bowel disease: a population-based study

Post-operative recurrence of Crohn's disease after definitive stoma: an underestimated risk

Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.

Prominence of ileal mucosa-associated microbiota to predict postoperative endoscopic recurrence in Crohn's disease

Reply

Reply

Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases.

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID)

Sa1960 Crohn's Disease Patients With High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

T cell clonal expansions in ileal Crohn's disease are associated with smoking behaviour and postoperative recurrence

Tailored treatment according to early post-surgery colonoscopy reduces clinical recurrence in Crohn's disease: a retrospective study

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study

Treatments for Crohn’s Disease–Associated Bowel Damage: A Systematic Review

Trough Levels and Antibodies to Infliximab May Not Predict Response to Intensification of Infliximab Therapy in Patients With Inflammatory Bowel Disease

Trough Levels and Antibodies to Ustekinumab are not Correlated to Response to Ustekinumab Treatment in Crohn's Disease Patients

Tu1881 HLA B27 Transgenic Rat: A New Animal Model of Postsurgical Ileitis in Inflammatory Bowel Disease